Document Classification

Section Type: METHODS

Text: Patients relapsed after adjuvant/neoadjuvant anthracycline-containing chemotherapy were randomized to : A) gemcitabine 1000 mg/m2 Day 1, 8 + docetaxel 75 mg/m2 Day 1 q3W ; B) gemcitabine 1250 mg/m2 Day 1, 8 + paclitaxel 175 mg/m2 Day 1 q3W ; C) gemcitabine 800 mg/m2 Day 1, 8, 15 + docetaxel 30 mg/m2 Day 1, 8, 15 q4W ; D) gemcitabine 800 mg/m2 Day 1, 15 + paclitaxel 80 mg/m2 Day 1, 8, 15 q4W.